Monday, 25 May 2026: Markets Hit Record Highs as Merck Surges and Nvidia Slips

Monday, 25 May 2026: Markets Hit Record Highs as Merck Surges and Nvidia Slips

From Morgans AM by Morgans Financial Limited

May 24, 2026 · 7 min

About this episode

US equity markets reached record highs with Merck leading gains while Nvidia experienced a decline.

US equity markets rallied on Friday (22 May) ahead of the holiday long weekend albeit finished off their best levels of the session – Dow rose +294-points or +0.58% to log a fresh record closing high of 50,579.70 for a second consecutive session after scaling a record intra-day peak (50,830.24) . Merck & Co rallied +5.64% to be the leading performer in the 30-stock index following a report by STAT News that its lung cancer treatment being developed with China-based Kelun-Biotech, sacituzumab tirumotecan , cut tumour progression risk by 65% and also yielded a survival benefit in a Phase 3 study conducted in China . The drug was used on patients in combination with Merck’s Keytruda, the company’s immunotherapy used to treat a wide variety of cancers. However, Nvidia Corp (down -1.9%) declined for a second session running following the release of its first quarter result after the close last Wednesday (20 May).

Topics covered

  • US equity markets
  • Merck
  • Nvidia
  • record highs
  • lung cancer treatment
  • investing

Keywords

  • US equity markets
  • Merck
  • Nvidia
  • record high
  • lung cancer treatment
  • investing

Mentioned in this episode

Organizations: Merck & Co, Kelun-Biotech, Nvidia Corp

Products: sacituzumab tirumotecan, Keytruda

Places: China

More episodes of Morgans AM

Explore listener stats, chart rankings, contacts and more on the Morgans AM podcast page.